$EIGR $GILD $REGN $LLY Glad that another drug is showing benefit in treating COVID-19. Eiger BioPharmaceuticals ($EIGR) Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19 ir.eigerbio.com/news-releas... Main take-aways of the study: - Lambda significantly accelerated viral decline - Viral clearance highly correlated with baseline viral loads - All Lambda-treated patients were below the infectivity threshold by Day 7 This is great news. There are more options out than remdesivir from $GILD, the $REGN AB cocktail and the likes. GLTA!
  • 2
2 Likes